DYNAVAX TECHNOLOGIES CORPDVAX
| Dec 31,
2011 | Dec 31,
2012 | Dec 31,
2013 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 |
|---|
| Net income (loss) | -49 | -70 | -67 | -91 | -107 | -112 | -95 | -159 | -153 | -75 | 77 | 293 |
|---|
| Depreciation and amortization | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 9 | 4 | 4 | 4 |
|---|
| Amortization of right-of-use assets | - | - | - | - | - | - | - | - | - | - | - | 3 |
|---|
| Inventory write-off | - | - | - | - | - | - | - | - | - | - | 3 | 34 |
|---|
| Loss (gain) on disposal of property and equipment and from lease termination | - | - | - | - | - | - | - | - | - | 0 | -0 | - |
|---|
| Amortization of premiums (accretion of discounts) on marketable securities | -1 | -1 | -1 | -1 | -1 | -0 | 0 | 2 | 1 | -1 | -0 | 4 |
|---|
| Loss on debt extinguishment | - | - | - | - | -2 | - | - | - | - | - | -5 | - |
|---|
| Fair Value Adjustment of Warrants | - | - | - | - | - | - | - | - | 8 | -4 | 49 | -2 |
|---|
| Stock compensation expense | 5 | 10 | 12 | 6 | 9 | 14 | 15 | 23 | 25 | 13 | 21 | 33 |
|---|
| Cost, Amortization | - | - | - | - | - | - | - | 11 | 9 | 3 | - | - |
|---|
| Non-cash interest expense | - | - | - | - | - | - | - | 3 | 5 | 3 | 2 | 1 |
|---|
| Tenant improvements provided by the landlord | - | - | - | - | - | - | - | - | -7 | -1 | - | - |
|---|
| Gain on sale of assets | - | - | - | - | - | - | - | - | - | 7 | 1 | 1 |
|---|
| Accounts and other receivables, net | - | - | - | - | - | -0 | -0 | 3 | 5 | 14 | 109 | 16 |
|---|
| Inventories, net | - | - | - | - | - | - | 0 | 19 | 22 | 22 | 0 | 32 |
|---|
| Prepaid manufacturing | - | - | - | - | - | - | - | - | - | 29 | 130 | -160 |
|---|
| Prepaid expenses and other current assets | - | - | - | - | -2 | -1 | 2 | 2 | 1 | 2 | 65 | 12 |
|---|
| Other assets | - | - | - | - | - | - | - | 4 | -2 | 0 | -0 | -0 |
|---|
| Accounts payable | -0 | 0 | -1 | -1 | 1 | 1 | -2 | 3 | 5 | -3 | -1 | 1 |
|---|
| CEPI accrual (Note 9) | - | - | - | - | - | - | - | - | - | - | 129 | -21 |
|---|
| Lease liabilities | - | - | - | - | - | - | - | - | 2 | 3 | -3 | 3 |
|---|
| Deferred revenue | 4 | 1 | -5 | 5 | -10 | -3 | - | - | - | 38 | 312 | -350 |
|---|
| Accrued and other liabilities | - | - | - | - | 9 | -12 | 3 | 13 | -9 | 3 | 40 | -25 |
|---|
| Net cash provided by (used in) operating activities | -47 | -44 | -59 | - | - | - | - | -131 | -121 | -92 | 336 | 63 |
|---|
| Acquisition of technology licenses | - | - | - | - | - | - | - | 11 | 7 | 7 | - | - |
|---|
| Purchases of marketable securities | 111 | 206 | 192 | 45 | 209 | 127 | 228 | 214 | 215 | 202 | 165 | 632 |
|---|
| Proceeds from maturities and redemptions of marketable securities | - | 169 | 142 | 137 | 130 | 221 | 120 | 284 | 202 | 149 | 188 | 322 |
|---|
| Proceeds from sales of marketable securities | - | - | - | - | - | - | - | - | - | 31 | - | - |
|---|
| Purchases of property and equipment, net | 1 | 3 | 2 | 2 | 7 | 8 | 1 | 4 | 22 | 4 | 9 | 7 |
|---|
| Proceeds from Sale of Productive Assets | - | - | - | - | - | - | - | - | - | 7 | 1 | 1 |
|---|
| Net cash (used in) provided by investing activities | -35 | -40 | -51 | - | - | - | - | 55 | -43 | -27 | 14 | -316 |
|---|
| Proceeds from long-term debt, net | - | - | - | 10 | - | - | - | 99 | 74 | - | - | - |
|---|
| Proceeds from Issuance of Common Stock | - | - | 81 | - | 184 | - | 186 | - | 66 | 109 | 28 | - |
|---|
| Proceeds from issuances of preferred stock, net | - | - | 44 | - | - | - | - | - | 14 | - | - | - |
|---|
| Proceeds from Convertible Debt | - | - | - | - | - | - | - | - | - | - | 220 | - |
|---|
| Purchases of capped call options | - | - | - | - | - | - | - | - | - | - | -27 | - |
|---|
| Repayment of long-term debt | - | - | - | - | - | - | - | - | - | - | 190 | - |
|---|
| Proceeds from warrants exercises | - | - | - | 0 | 0 | - | - | - | - | - | 18 | 8 |
|---|
| Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net | - | - | - | - | - | - | - | - | - | 0 | 7 | 10 |
|---|
| Proceeds from Stock Plans | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
|---|
| Net cash provided by financing activities | 91 | 59 | 125 | - | - | - | - | 99 | 154 | 109 | 56 | 20 |
|---|
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash | - | - | - | - | - | - | - | -0 | -0 | 1 | -1 | -0 |
|---|
| Net increase (decrease) in cash and cash equivalents, and restricted cash | - | - | - | - | - | - | - | 23 | -10 | -8 | 404 | -234 |
|---|
| Income Taxes Paid | - | - | - | - | - | - | - | - | - | - | 1 | 2 |
|---|
| Cash paid during the year for interest | - | - | - | - | - | - | - | 7 | 12 | 17 | 10 | 6 |
|---|
| Non-cash acquisition of technology license | - | - | - | - | - | - | - | 13 | - | - | - | - |
|---|
| Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | - | - | - | 3 | 0 | 1 | 1 |
|---|
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | - | - | - | - | - | - | - | - | 41 | - | 2 | 3 |
|---|